Search by Drug Name or NDC

NDC 72865-0103-01 Sildenafil 100 mg/1 Details

Sildenafil 100 mg/1

Sildenafil is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by XLCARE Pharmaceuticals INC.. The primary component is SILDENAFIL CITRATE.

MedlinePlus Drug Summary

Sildenafil (Viagra) is used to treat erectile dysfunction (impotence; inability to get or keep an erection) in men. Sildenafil (Revatio) is used to improve the ability to exercise in adults with pulmonary arterial hypertension (PAH; high blood pressure in the vessels carrying blood to the lungs, causing shortness of breath, dizziness, and tiredness). Children should not usually take sildenafil, but in some cases, a doctor may decide that sildenafil (Revatio) is the best medication to treat a child's condition. Sildenafil is in a class of medications called phosphodiesterase (PDE) inhibitors. Sildenafil treats erectile dysfunction by increasing blood flow to the penis during sexual stimulation. This increased blood flow can cause an erection. Sildenafil treats PAH by relaxing the blood vessels in the lungs to allow blood to flow easily. If you are taking sildenafil to treat erectile dysfunction, you should know that it does not cure erectile dysfunction or increase sexual desire. Sildenafil does not prevent pregnancy or the spread of sexually transmitted diseases such as human immunodeficiency virus (HIV).

Related Packages: 72865-0103-01
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Sildenafil

Product Information

NDC	72865-0103
Product ID	72865-103_f26fd1e1-7c9e-b45b-e053-2995a90a162d
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Sildenafil
Proprietary Name Suffix	n/a
Non-Proprietary Name	Sildenafil
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	100
Active Ingredient Units	mg/1
Substance Name	SILDENAFIL CITRATE
Labeler Name	XLCARE Pharmaceuticals INC.
Pharmaceutical Class	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA202659
Listing Certified Through	2024-12-31

Package

NDC 72865-0103-01 (72865010301)

Pricing Information	N/A
NDC Package Code	72865-103-01
Billing NDC	72865010301
Package	100 TABLET, FILM COATED in 1 BOTTLE (72865-103-01)
Marketing Start Date	2019-08-01
NDC Exclude Flag	N